Turkish Version of the Hand20 Questionnaire With Carpal Tunnel Syndrome

April 16, 2024 updated by: Neslihan Torun, Hasan Kalyoncu University

Validity Study of the Turkish Version of the Hand20 Questionnaire With Carpal Tunnel Syndrome

The questionnaire will be investigated by administering the Hand-20 questionnaire and the Boston Carpal Tunnel Syndrome Questionnaire to patients with carpal tunnel syndrome, one week apart.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

Questionnaires, which are used to express the perception of difficulty and hand functionality during daily living activities of individuals with carpal tunnel syndrome, and most importantly, which are easy to administer, should be preferred in order to plan a patient-specific treatment program with these results. Self-administered questionnaires showing the physical dimension of recovery are effective and sensitive to change.

Hand20 is a short, easy-to-understand and visual questionnaire used to evaluate disorders caused by upper extremity pathologies, developed by Suzuki et al. in 2010 and proven to be valid in upper extremity diseases by Töre et al. In this questionnaire consisting of 20 questions, the answer to each question is graded between 0 and 10 (0: No restrictions, 10: Impossible). The best score is 0, the worst score is 100.

Boston carpal tunnel syndrome questionnaire (BKTSA) will be used to evaluate the functionality level and symptom severity of the patients. In this questionnaire, which consists of 2 parts: symptom severity and functional capacity, a separate average score will be calculated for each part by dividing the total score obtained by the number of questions. An increased score indicates decreased functional capacity and increased symptom severity.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 60 years (Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Individuals diagnosed with carpal tunnel syndrome

Description

Inclusion Criteria:

  • Patients aged 25-60 years
  • Patients diagnosed with carpal tunnel
  • Patients who volunteered for treatment

Exclusion Criteria:

  • Patients who do not agree to volunteer
  • Patients who have undergone surgery from the wrist region

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Boston carpal tunnel syndrome questionnaire
Other: Investigation of the validity of the Hand-20 Questionnaire in individuals with carpal tunnel syndrome
To investigate the validity and reliability of the Hand-20 questionnaire used in individuals with upper extremity disease by comparing it with the Boston carpal tunnel syndrome questionnaire in individuals with carpal tunnel syndrome in Turkey
Hand-20 questionnaire
Other: Investigation of the validity of the Hand-20 Questionnaire in individuals with carpal tunnel syndrome
To investigate the validity and reliability of the Hand-20 questionnaire used in individuals with upper extremity disease by comparing it with the Boston carpal tunnel syndrome questionnaire in individuals with carpal tunnel syndrome in Turkey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Investigation of the Validity of the Hand-20 Questionnaire in Individuals with Carpal Tunnel Syndrome
Time Frame: 1 week apart
1 week apart

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hasan Kalyoncu University

Investigators

  • Study Director: Aysenur Tuncer, PhD, Hasan Kalyoncu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Estimated)

May 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

February 21, 2022

First Submitted That Met QC Criteria

February 21, 2022

First Posted (Actual)

March 2, 2022

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

September 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Hasan Kalyoncu Universty

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Clinical Trials on Investigation of the validity of the Hand-20 Questionnaire in individuals with carpal tunnel syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe